F. Pijnappel

Incidence of HCV reinfection among HIV-positive MSM and its association with sexual risk behavior: a longitudinal analysis.

M. van der Valk, A. Boonstra, J. V. D. van der Meer, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.

M. Hiligsmann, W. Viechtbauer, J. Veenstra, 2017, The Lancet. Infectious diseases.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands

B. Berkhout, M. Wegdam, R. Meijering, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged Individuals

T. van der Poll, P. Lips, F. Verbraak, 2018, The Journal of infectious diseases.

Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation

J. Veenstra, M. de Bruin, B. Wijnen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessing treatment-as-usual provided to control groups in adherence trials: Exploring the use of an open-ended questionnaire for identifying behaviour change techniques

M. de Bruin, J. Prins, A. Dima, 2015, Psychology & health.

Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial

L. Flobbe, M. van der Valk, D. Verhagen, 2023, Trials.